SCHEMBL4559012

SCHEMBL4559012

O=C(O)c1c[nH]c2c(F)c(Cc3ccc(-c4ccccc4)cc3)cc(F)c2c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 3/20 0.43
CSNK2A2 P19784 2/20 0.41
CSNK2B P67870 2/20 0.41
CSNK2A1 P68400 2/20 0.41
PTPN1 P18031 1/20 0.41
PRKAB2 O43741 2/20 0.39
PRKAG1 P54619 2/20 0.39
PRKAA2 P54646 2/20 0.39
PRKAA1 Q13131 2/20 0.39
PRKAG3 Q9UGI9 2/20 0.39
PRKAG2 Q9UGJ0 2/20 0.39
PRKAB1 Q9Y478 2/20 0.39
CYP1A2 P05177 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
AXL P30530 1/20 0.38
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4650143 0.90 CSNK2A2 (0.43) CSNK2A2CSNK2BCSNK2A1PRKAB2PRKAG1
SCHEMBL4650790 0.86 KDM5A (0.42) CSNK2A2CSNK2BCSNK2A1PRKAB2PRKAG1
SCHEMBL4650109 0.86 CYP1A2 (0.46) CSNK2A2CSNK2BCSNK2A1PRKAB2PRKAG1
SCHEMBL4650001 0.84 CSNK2A2 (0.39) CHRM1CSNK2A2CSNK2BCSNK2A1PRKAB2
SCHEMBL4649448 0.84 CSNK2A1 (0.44) CSNK2A2CSNK2BCSNK2A1PRKAB2PRKAG1
SCHEMBL4650035 0.83 CSNK2A2 (0.43) CSNK2A2CSNK2BCSNK2A1PRKAB2PRKAG1
SCHEMBL4650012 0.82 PNP (0.41) CSNK2A2CSNK2BCSNK2A1PRKAB2PRKAG1
SCHEMBL4649980 0.81 CYP1A2 (0.43) CSNK2A2CSNK2BCSNK2A1CYP1A2HSD17B10
SCHEMBL4649199 0.81 ALDH1A1 (0.43) CSNK2A2CSNK2BCSNK2A1ALDH1A1HPGD
SCHEMBL4650011 0.81 KDM4C (0.45) CSNK2A2CSNK2BCSNK2A1PRKAB2PRKAG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2037739-A2 BENZYL-SUBSTITUTED QUINOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS Merck & Co., Inc. (US) 2009-03-25 EP claimed
WO-2008002621-A2 BENZYL-SUBSTITUTED QUINOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK & CO., INC. (US) 2008-01-03 WO claimed